Back to Journals » Neuropsychiatric Disease and Treatment » Volume 13

Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairments

Authors Jiao CX, Zhou H, Yang CX, Ma C, Yang YX, Mao RR, Xu L, Zhou QX

Received 8 November 2016

Accepted for publication 28 February 2017

Published 26 April 2017 Volume 2017:13 Pages 1181—1192


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Wai Kwong Tang

Chun-Xiang Jiao,1–3,* Heng Zhou,1,4,* Chun-Xian Yang,1,2 Chen Ma,1,2 Yue-Xiong Yang,1,2 Rong-Rong Mao,1,2 Lin Xu,1,2 Qi-Xin Zhou1,2

1Laboratory of Learning and Memory, Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, CAS, Kunming, 2Kunming College of Life Sciences, University of Chinese Academy of Sciences, 3Yunnan Provincial Key Laboratory of Entomollogical Biopharmaceutical Research and Development, College of Pharmacy and Chemistry, Dali University, Dali, 4School of Life Sciences, University of Science and Technology of China, Hefei, People’s Republic of China

*These authors contributed equally to this work

Abstract: With respect to the high burden of ischemic stroke and the absence of pharmacological treatment for promoting rehabilitation, promising candidates with specific effects on long-term functional recovery are highly desired. Candidates need reasonable experimental paradigms to evaluate the long-term functional outcome focused on ischemia-induced sensorimotor and memory deficits. “Danshen”, a traditional Chinese herb, has long been used to treat coronary and cerebral vascular diseases as well as dementia. Salvianolic acid A (SAA), one of the major active ingredients of Danshen, was demonstrated to be effective in protecting against cerebral ischemic injury. Here, employing an experimental stroke model induced by photothrombosis in the unilateral frontal cortex of rats, we investigated whether SAA has long-term protective effects on ischemia-induced sensorimotor and memory deficits in our behavioral tests. The results indicated that a single SAA treatment improved the cortical ischemia-induced sensorimotor deficits during 15 days’ cylinder test period, and alleviated ischemia-induced sustained spatial memory impairments during the 2 months’ dependent Morris Water Maze (MWM) tests. In addition, either ischemic injury or SAA treatment did not show any changes compared with sham group in other behavioral tests including rotarod tests, swimming speed in MWM tests, open field tests, elevated plus maze tests, treadmill tests and forced swimming tests. The results reveal that the cognitive deficits are not the results of animal’s anxiety or confounding motor impairments. Overall, the present paradigm appears suitable for the preclinical evaluation of the long-term effects of pharmacological treatments on ischemic stroke. Meanwhile, SAA might have therapeutic potential for the treatment of memory deficits associated with ischemic stroke.

Keywords: salvianolic acid A, memory impairments, dementia, ischemic stroke

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]